Clinical Trial Update: A Long-term Study of NPC-12G Gel in Neurofibromatosis Type I [Phase 3]

View source ↗

Summary

Phase 3 long-term study of NPC-12G Gel in Neurofibromatosis Type I has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis

Drugs mentioned

• NPC-12G Gel

Snippet

Sponsor: Nobelpharma | Conditions: Neurofibromatosis | Phase 3 | Status: TERMINATED